You are here
Philips to buy cardiac devices firm Spectranetics for US$1.7b
ROYAL Philips NV's US$1.7 billion deal to buy Spectranetics Corp, a US maker of devices to treat cardiac disease, shows the Dutch company is moving more aggressively to bolster its growing health-care business.
Philips will offer US$38.50 a share in cash for the Colorado
- CALL +65 6388 3838
- EMAIL firstname.lastname@example.org